Search

everythinglearnresearchcommunity

for

Search:↓

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Finasteride increases risk of sleep apnea and insomnia.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Use minoxidil or finasteride first, then try HairMax LaserComb if needed.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Bimatoprost ophthalmic solution 0.03% safely and effectively increases eyelash growth when applied to the upper eyelid.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

Minoxidil helps treat pattern hair loss in both men and women.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.